- Home
- WFCF vs IKNA Comparison
WFCF vs IKNA Comparison
Compare WFCF & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFCF
- IKNA
- Stock Information
- Founded
- WFCF 1996
- IKNA 2016
- Country
- WFCF United States
- IKNA United States
- Employees
- WFCF N/A
- IKNA N/A
- Industry
- WFCF Computer Software: Prepackaged Software
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- WFCF Technology
- IKNA Health Care
- Exchange
- WFCF Nasdaq
- IKNA Nasdaq
- Market Cap
- WFCF 59.0M
- IKNA 63.7M
- IPO Year
- WFCF 2011
- IKNA 2021
- Fundamental
- Price
- WFCF $11.33
- IKNA N/A
- Analyst Decision
- WFCF
- IKNA Buy
- Analyst Count
- WFCF 0
- IKNA 2
- Target Price
- WFCF N/A
- IKNA $13.50
- AVG Volume (30 Days)
- WFCF 2.7K
- IKNA 434.6K
- Earning Date
- WFCF 08-07-2025
- IKNA 07-24-2025
- Dividend Yield
- WFCF N/A
- IKNA N/A
- EPS Growth
- WFCF N/A
- IKNA N/A
- EPS
- WFCF 0.38
- IKNA N/A
- Revenue
- WFCF $25,437,000.00
- IKNA N/A
- Revenue This Year
- WFCF N/A
- IKNA N/A
- Revenue Next Year
- WFCF N/A
- IKNA N/A
- P/E Ratio
- WFCF $29.94
- IKNA N/A
- Revenue Growth
- WFCF N/A
- IKNA N/A
- 52 Week Low
- WFCF $9.26
- IKNA $0.97
- 52 Week High
- WFCF $13.50
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- WFCF 54.65
- IKNA 15.31
- Support Level
- WFCF $11.16
- IKNA $14.40
- Resistance Level
- WFCF $11.50
- IKNA $17.76
- Average True Range (ATR)
- WFCF 0.18
- IKNA 0.88
- MACD
- WFCF -0.02
- IKNA -1.60
- Stochastic Oscillator
- WFCF 55.82
- IKNA 0.00
About WFCF Where Food Comes From Inc.
Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.